research reports and media, page-4104

No you haven't missed anything, as Babba mentions we have a water tight contract in place from 25 years from Licensing.

Yes the study in NSW is in regards to PPS but we have the patent for OA with BMLS as well as pain.

Our patent doesn't just cover PPS in SubQ and Sodium format, it covers all salts, here is an excerpt:


The term“acceptable salts" include, but are not limited to, inorganic acid salts such as hydrochloride, hydrobromide, sulfate, phosphate and the like; organic acid salts such as formate, acetate, trifluoroacetate, maleate, tartrate and the like; sulfonates such as methanesulfonate, benzenesulfonate, p-toluenesulfonate and the like; amino acid salts such as arginate, asparaginate, glutamate and the like; metal salts such as sodium salt, potassium salt, cesium salt and the like; alkaline earth metals such as calcium salt, magnesium salt and the like; and organic amine salts such as triethylamine salt, pyridine salt, picoline salt, ethanolamine salt, triethanolamine salt, discyclohexylamine salt, N,N'-dibenzylethylenediamine salt and the like.



OA/BME:

According to another aspect, there is provided use of a polysulfated polysaccharide or an acceptable salt thereof, in the treatment of bone marrow edema lesions as assessed by magnetic resonance imaging (MRI) in a mammal.





Want to use PPS to treat OA? Sure go ahead, but you must first PROVE there is no trace of BME first.


That's not going to be practical or easy for anyone else.







Personal views expressed.






Ref: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020073089&tab=PCTDESCRIPTION
https://patentscope.wipo.int/search/en/detail.jsf?docId=US300735814&tab=PCTDESCRIPTION